NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the ...
Expanded leadership team positioned to advance the company’s development and commercialization plans “This is a transformational time for Prilenia,” said Dr. Michael R. Hayden, CEO of Prilenia. “Rob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results